Application Nr Approved Date Route Status External Links
NDA211349 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Xospata Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients Who Have Relapsed Or Refractory Acute Myeloid Leukemia (Aml) With A Flt3 Mutation As Detected By An Fda-Approved Test. ( 1.1 ) 1.1 Relapsed Or Refractory Acute Myeloid Leukemia Xospata Is Indicated For The Treatment Of Adult Patients Who Have Relapsed Or Refractory Acute Myeloid Leukemia (Aml) With A Fms-Like Tyrosine Kinase 3 (Flt3) Mutation As Detected By An Fda-Approved Test.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Gilteritinib Fumarate GILTERITINIB FUMARATE ZINC113476229

Comments